Home dialysis therapies are flexible kidney replacement strategies with documented clinical benefits. While the incidence of end-stage kidney disease continues to increase globally, the use of home dialysis remains low in most developed countries. Multiple barriers to providing home dialysis have been noted in the published literature. Among known challenges, gaps in clinician knowledge are potentially addressable with a focused education strategy. Recent national surveys in the United States and Australia have highlighted the need for enhanced home dialysis knowledge especially among nephrologists who have recently completed training. Traditional in-person continuing professional educational programmes have had modest success in promoting home dialysis and are limited by scale and the present global COVID-19 pandemic. We hypothesize that the use of a 'Hub and Spoke' model of virtual home dialysis mentorship for nephrologists based on project ECHO would support home dialysis growth. We review the home dialysis literature, known educational gaps and plausible educational interventions to address current limitations in physician education. K E Y W O R D S home dialysis, home haemodialysis, peritoneal dialysis, project ECHO, virtual mentorship
| INTRODUCTIONThe Advancing American Kidney Health (AAKH) Initiative 1 in the United States has clearly signalled that home dialysis uptake needs to increase. The nephrology community has been challenged to provide either a kidney transplant or a home dialysis modality for 80% of patients requiring end-stage kidney disease (ESKD) care by 2025.
Home dialysis therapies (home haemodialysis [HHD] and peritoneal dialysis [PD]) are cost-effective 2 and highly preferred modalities of renal replacement therapies when nephrologists and patients are surveyed. [3][4][5][6][7][8] Home dialysis therapies have been associated with improved quality of life, 9 greater satisfaction with therapy, 9 and improved blood pressure control. 10 Patients on HHD have reductions in left ventricular mass 10 while patients on PD have improved preservation of native kidney function when compared to patients on incentre haemodialysis (ICHD). 11 This has led nephrologists and professional bodies to adopt a 'Home First' culture when educating patients about kidney replacement therapies. 3 The incidence and prevalence of home dialysis therapies vary internationally and are explained by various clinical, social and economic factors. 12 We acknowledge that the barriers to home therapies will differ in different contexts. However, the relatively low rates of home dialysis therapies in the United States warrant further attention. According to the most recent USRDS data, 13,14 approximately 85% of incident ESKD patients in the United States begin ICHD as the initial mode of therapy. Only 10.9% of the incident ESKD population in 2018 initiated PD and even fewer initiated HHD as initial therapy (0.3% of incident patients with ESKD).The low rates of home modality uptake in the United States are not fully explained by c...